3billion participates in ESHG 2023

3billion people participated in ESHG 2023, held in Glasgow, Scotland, UK, from June 10th to 13th.

This year, we operated a booth, held a Corporate Satellite event, and presented a poster on the topic of “Diagnostic Performance of Exome Sequencing on 18,995 Patients with Suspected Rare Genetic Disorders” after participating in the event for the second time last year.

Our booth, designed with the slogan “Exome is great, but Genome is better,” featured an on-site event where we distributed gifts such as fans and medicine. We also offered a special promotion bundling Exome and Genome services together. We had the opportunity to engage in meaningful conversations with many visitors during the event.

During the Corporate Satellite held on the morning of June 11th, Dr. Alisdair McNeill and Prof. Tinatin Tkemaladze provided detailed explanations of cases diagnosed through 3billion’s services. Chief Medical Officer Dr. GoHoon Seo presented 3billion’s WGS service under the theme of “Clinical Utility of WGS for Patients Suspected with Genetic Disease.”

At this conference, 3billion gained a deep understanding of the challenges in the medical field related to rare diseases in Europe. Armed with these valuable insights, we are now committed to pursuing new collaboration opportunities and continuing our endeavors to expand into the European market.